IBG Beteiligungsgesellschaft Sachsen-Anhalt

InLine-Med GmbH is a German company that specializes in developing assistance devices designed to aid radiologists in performing needle-based interventions, particularly in the context of cancer diagnosis and treatment. Founded in 2019 and based in Magdeburg, the company offers a range of products including navigation and assistance devices, surgical tools, needle alignment tools, and marker grids for anatomical orientation. InLine-Med's innovative approach integrates artificial intelligence with high-quality biopsy needles and guiding tools, enhancing the efficiency, accuracy, and safety of procedures. The company's solutions facilitate precise needle placement, addressing challenges posed by space constraints and the complexity of existing assistance devices. By utilizing AI algorithms, InLine-Med enables clinicians to visualize and plan interventions effectively, significantly reducing the number of punctures needed and minimizing risks for both patients and healthcare providers. The comprehensive suite of assistance tools and biopsy needles is competitively priced, making it accessible for clinicians seeking to improve their diagnostic and treatment capabilities.

COMAN Software GmbH is a software development company specializing in project management solutions for the machine and plant construction industry. Founded in 2018 and based in Gardelegen, Germany, the company offers a comprehensive platform that facilitates the efficient management of construction projects. Its software features real-time data capture, project data importation, and status reporting, which enhance transparency and security throughout the project lifecycle. By streamlining processes and enabling digital information exchange, COMAN's solutions help reduce construction time and improve planning quality. The company also provides a mobile application for onsite information gathering and offers various services, including support, training, consulting, and project initialization. COMAN Software aims to improve collaboration and communication among teams, ultimately allowing businesses to deliver projects on time and within budget.

Lab-on-Fiber GmbH is a German company based in Halle that specializes in the development, commercialization, and production of advanced fiber delivery and laser systems for medical applications. The company focuses on creating smart medical laser probes that are designed to enhance outcomes in minimally invasive surgeries. Its product offerings include surgical and urology fiber probes, which utilize optimized radiation profiles and temperature monitoring at the probe surface. These innovations aim to improve patient safety, reduce operating times, and increase the success rate of treatments, thereby addressing key challenges in laser surgery.

TESVOLT GmbH, founded in 2014 and based in Wittenberg, Germany, specializes in the manufacture of lithium battery storage systems aimed at the commercial and industrial sectors. The company is recognized as a leader in energy storage solutions within Germany and Europe, focusing on enabling businesses to reduce their energy dependency and contribute to the energy transition. TESVOLT produces intelligent storage systems with capacities ranging from 10 kilowatt-hours to multiple megawatt-hours, ensuring high quality and TÜV-certified safety. Its products can integrate with various renewable energy sources, including solar, wind, and biogas. The company operates a carbon-neutral gigafactory for series production and has received numerous accolades for its innovations, including the German Entrepreneur Award and the TOP 100 “Innovator of the Year.” Co-founders Daniel Hannemann and Simon Schandert leverage their extensive experience in the photovoltaic sector to advance the development of economical and efficient storage solutions.

Arzneimittelwerk Warngau develops and markets drug delivery systems. Its portfolio includes active ingredient/biodegradable implants and transdermal systems in the areas of oncology, pain therapy, and neurology. It focuses on transdermal passive and microchip controlled patches, as well as subcutaneous biodegradable implants. Wilfried Fischer founded Arzneimittelwerk Warngau in 2008. It has its headquarters in Warngau in Germany.

2tainment GmbH is a video game publisher and development studio based in Magdeburg, Germany, founded in 2014. The company specializes in creating and marketing both hardware and software entertainment products on an international scale. Its diverse portfolio includes a variety of games such as Tech Corp, BIOTOPE – Aquarium Simulator, Air Missions: HIND, Super Street, Club Manager 2017, and Crashday. In addition to gaming, 2tainment develops high-quality accessories for PC, mobile, and video games, such as game pads and keyboards, which complement its software offerings. The company also emphasizes the development of virtual and augmented reality content and collaborates with external studios to market their games. Beyond gaming, 2tainment engages in research and development, exploring innovative medical projects that leverage its expertise in AR and VR to enhance treatment methods. This multifaceted approach benefits players, developers, distributors, and retailers alike, ensuring that each product receives focused attention and support.

Arzneimittelwerk Warngau develops and markets drug delivery systems. Its portfolio includes active ingredient/biodegradable implants and transdermal systems in the areas of oncology, pain therapy, and neurology. It focuses on transdermal passive and microchip controlled patches, as well as subcutaneous biodegradable implants. Wilfried Fischer founded Arzneimittelwerk Warngau in 2008. It has its headquarters in Warngau in Germany.

Micropelt is a startup that evolved from a collaboration between Infineon Technologies AG and the Fraunhofer Institute for Physical Measurement Techniques in Freiburg, Germany. The company specializes in the development of thin film thermoelectric components, leveraging semiconductor manufacturing processes to create energy harvesting systems. These systems are designed to power micro-actuators and sensors, focusing specifically on thermoelectric cooling chips and thermogenerators. Micropelt's products are utilized in various applications, including chip spot cooling, biomedical devices, heating, ventilation, air-conditioning systems, and optical sensors. Their innovative technology aims to enhance temperature management in individual rooms while contributing to CO2 reduction and improving overall user comfort.

Vivoryon Therapeutics AG is a clinical stage biopharmaceutical company based in Halle, Germany, specializing in the research and development of therapeutic products for Alzheimer's disease and cancer. The company's lead candidate, PQ912, is a small molecule QC inhibitor that has completed Phase IIb clinical trials for Alzheimer's disease and is also being explored for cancer treatment. Additionally, Vivoryon is developing PQ1565, a small molecule inhibitor targeting glutaminyl-peptide cyclotransferase-like for cancer therapy, along with a monoclonal antibody aimed at enhancing the clearance of toxic pyroglutamate-Abeta. The company collaborates with various institutions, including the University Medical Center Schleswig-Holstein and Nordic Bioscience, to advance its clinical and research initiatives. Originally founded in 1997 as Probiodrug AG, the company rebranded to Vivoryon Therapeutics AG in June 2019.

TME Pharma is a clinical-stage biopharmaceutical company focused on enhancing cancer treatment by targeting the tumor microenvironment. The company develops biostable aptamers and mirror image nucleic acids, with its leading products, NOX-A12 and NOX-E36, classified as Spiegelmers. This innovative class of drugs offers specific advantages over traditional therapies, aiming to improve the effectiveness of cancer treatments. TME Pharma has also established a strategic alliance with Pfizer, Inc. The company is headquartered in Berlin, Germany, and is dedicated to advancing its research to benefit patients battling cancer.

Vivoryon Therapeutics AG is a clinical stage biopharmaceutical company based in Halle, Germany, specializing in the research and development of therapeutic products for Alzheimer's disease and cancer. The company's lead candidate, PQ912, is a small molecule QC inhibitor that has completed Phase IIb clinical trials for Alzheimer's disease and is also being explored for cancer treatment. Additionally, Vivoryon is developing PQ1565, a small molecule inhibitor targeting glutaminyl-peptide cyclotransferase-like for cancer therapy, along with a monoclonal antibody aimed at enhancing the clearance of toxic pyroglutamate-Abeta. The company collaborates with various institutions, including the University Medical Center Schleswig-Holstein and Nordic Bioscience, to advance its clinical and research initiatives. Originally founded in 1997 as Probiodrug AG, the company rebranded to Vivoryon Therapeutics AG in June 2019.

EUCODIS Bioscience GmbH is an enzyme engineering company based in Vienna, Austria, with a subsidiary in Germany. Founded in 2007, the company specializes in the manufacture of high-performing enzyme solutions for diverse applications across the biopharmaceutical, fine chemicals, food and feed, and cosmetics industries. Its product portfolio includes lipases, peroxidases, phospholipase D, nitril hydratases, and various other enzymes, such as catalases and dehydrogenases. These enzymes facilitate processes including the stereospecific resolution of chiral alcohols for API synthesis, the production of sensitive esters, and the synthesis of cosmetic emollient esters. EUCODIS Bioscience also provides services in protein and enzyme engineering, bioprocess development, formulation and analysis, and industrial manufacturing, catering to a growing demand for environmentally sustainable production methods.

TME Pharma is a clinical-stage biopharmaceutical company focused on enhancing cancer treatment by targeting the tumor microenvironment. The company develops biostable aptamers and mirror image nucleic acids, with its leading products, NOX-A12 and NOX-E36, classified as Spiegelmers. This innovative class of drugs offers specific advantages over traditional therapies, aiming to improve the effectiveness of cancer treatments. TME Pharma has also established a strategic alliance with Pfizer, Inc. The company is headquartered in Berlin, Germany, and is dedicated to advancing its research to benefit patients battling cancer.

MetraTec GmbH, established in 2006 and headquartered in Magdeburg, Germany, specializes in manufacturing and supplying Radio Frequency Identification (RFID) hardware products. Its portfolio includes HF and UHF readers, gates, starter kits, RFID readers/writers, multiplexers, antennas, transponders, and modules. MetraTec's products cater to diverse industries such as logistics, retail, healthcare, and security, serving applications like access control, document management, payment systems, and indoor localization. The company also offers custom solutions tailored to specific client needs, primarily serving system integrators, OEM customers, and research institutes worldwide, with a focus on Europe.